Federal contract award
75H70625F03134
COST PER REPORTABLE RESULT, PATIENT DIAGNOSTIC CHEMISTRY AND COAGULATION ANALYZER CONSUMABLES. THE PERIOD OF PERFORMANCE WILL BE APRIL 1, 2025 THROUGH JUNE 30, 2025.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | GREAT PLAINS AREA INDIAN HEALTH SVC |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | 75H70621A00004 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $20.7K |
| Current contract value | $20.7K |
| Potential contract value / ceiling | $20.7K |
| Start date | Mar 4, 2025 |
| Current end date | Jun 30, 2025 |
| Potential end date | Feb 6, 2026 |
| Latest award activity | Feb 6, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 6, 2026 | P00001 | $-3.3K | MODIFICATION NO. ONE(1) TO DE-OBLIGATE BPA CALL 75H70625F03134 EXCESS FUNDS THAT PROVIDE COST PER REPORTABLE CHEMISTRY TESTING RESULT FOR THE KYLE HEALTH CENTER. THE VENDOR APPROVED THE DE-OBLIGATION VIA EMAIL ON 1/29/2026. |
| Mar 12, 2025 | 0 | $24.0K | COST PER REPORTABLE RESULT, PATIENT DIAGNOSTIC CHEMISTRY AND COAGULATION ANALYZER CONSUMABLES. THE PERIOD OF PERFORMANCE WILL BE APRIL 1, 2025 THROUGH JUNE 30, 2025. |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.